Study Title
NORTH: A Phase II Study of Panobinostat in Paediatric& Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma& Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma
Protocol ID
ACCT008 (NORTH)
Condition/s
Osteosarcoma
Malignant Rhabdoid Tumour
Neuroblastoma
Atypical Teratoid/Rhabdoid Tumour (AT/RT)
Malignant Rhabdoid Tumour
Neuroblastoma
Atypical Teratoid/Rhabdoid Tumour (AT/RT)
Diagnosis Stage
New diagnosis
Relapse/refractory
Relapse/refractory
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 40 years of age
ANZCTR
ACTRN12618000321246
| Study Title | NORTH: A Phase II Study of Panobinostat in Paediatric& Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma& Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma |
|---|---|
| Protocol ID | ACCT008 (NORTH) |
| Disease (Sub Disease) | Osteosarcoma Malignant Rhabdoid Tumour Neuroblastoma Atypical Teratoid/Rhabdoid Tumour (AT/RT) |
| Diagnosis Stage | New diagnosis Relapse/refractory |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group |
| Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374371&isReview=true |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 17/08/2018 |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | up to 40 years of age |
| ANZCTR | ACTRN12618000321246 |